FedSmith.com Users Favor Inclusion of Obesity Drugs in FEHB

The Office of Personnel Management recently announced it was not permissible for insurance carriers to exclude obesity drugs under FEHB on the basis that obesity is a lifestyle condition. We asked our users what their thoughts were about this and the majority of responses indicate that the prospect of having coverage for obesity drugs would be a welcome change.

FLRA Member Pizzella on Excessive Interference and Abrogation

In a negotiability case involving SSA and AFGE, FLRA Member Pizzella reminded the other members of a recent court ruling reversing a decision and taking those members to task for a theory that the court concluded ended up with two separate results on the same issue depending on which process it arose in. Member Pizzella’s opinion is quoted verbatim in the article and the author suggests it’s worth a read by practitioners.